384
Participants
Start Date
June 8, 2023
Primary Completion Date
October 18, 2024
Study Completion Date
October 18, 2024
VER-01
Standardized oleoresin of Cannabis sativa L. folium cum flore, THC-chemotype (cannabis leaves and - flowers), corresponding to 21 mg (-)-trans-Δ9-Tetra-hydrocannabinol (THC) per gram drug product
Opioid therapy
The patient-specific selection of the marketed opioid (based on standard of care and provided for this study) is at the discretion of the investigator and made at Visit 1, i.e., before randomization at Visit 2.
Rheumazentrum Prof. Dr. med. Gunther Neeck, Bad Doberan
Medizinische Hochschule Hannover (MHH), Hanover
Vertanical GmbH
INDUSTRY